科研之友
微信
新浪微博
Facebook
分享链接
摘要
Widespread application of beta cell replacement to obtain insulin independence in people with type 1 diabetes requires an unlimited source of insulin-producing cells and the ability to block the pathological immune response. Recent reports in Nature Medicine and Nature Biotechnology present a creative bioengineering strategy for achieving these goals.
- 出版日期2016-4-7
